Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - lenalidomidum - capsule rigide - lenalidomidum 15.0 mg, amylum pregelificatum, cellulosum microcristallinum, carmellosum natricum conexum, silica colloidalis anhydrica, natrii stearylis fumaras, kapselhülle: titanii dioxidum, gelatina, drucktinte: lacca, e 172 (rubrum), propylenglycolum, simeticonum, pro capsula corresp. natrium 0.986 mg. - onkologikum - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - lenalidomidum - capsule rigide - lenalidomidum 20.0 mg, amylum pregelificatum, cellulosum microcristallinum, carmellosum natricum conexum, silica colloidalis anhydrica, natrii stearylis fumaras, kapselhülle: e 172 (flavum), titanii dioxidum, e 132, gelatina, drucktinte: lacca, e 172 (rubrum), propylenglycolum, simeticonum, pro capsula corresp. natrium 1.282 mg. - onkologikum - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - lenalidomidum - capsule rigide - lenalidomidum 25.0 mg, amylum pregelificatum, cellulosum microcristallinum, carmellosum natricum conexum, silica colloidalis anhydrica, natrii stearylis fumaras, kapselhülle: titanii dioxidum, gelatina, drucktinte: lacca, propylenglycolum, e 172 (nigrum), kalii hydroxidum, pro capsula corresp. natrium 1.579 mg. - onkologikum - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - abirateroni acetas - compresse rivestite con film - abirateroni acetas 500 mg, carmellosum natricum conexum, natrii laurilsulfas, povidonum k 30, cellulosum microcristallinum, lactosum monohydricum 68.0 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), e 171, macrogolum 3350, talcum, e 172 (rubrum), e 172 (nigrum), pro compresso obducto corresp. natrium 10.21 mg. - prostatico - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - abirateroni acetas - compresse rivestite con film - abirateroni acetas 1000 mg, carmellosum natricum conexum, natrii laurilsulfas, povidonum k 30, cellulosum microcristallinum, lactosum monohydricum 136.0 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), e 171, macrogolum 3350, talcum, pro compresso obducto corresp. natrium 20.41 mg. - prostatico - synthetika

Unione Europea - italiano - EMA (European Medicines Agency)

mylan ireland limited - rivaroxaban - venous thromboembolism; pulmonary embolism; acute coronary syndrome; stroke; coronary artery disease; peripheral arterial disease; atrial fibrillation - agenti antitrombotici - rivaroxaban mylan co-administered with acetylsalicylic acid (asa) alone or with asa plus clopidogrel or ticlopidine, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers.  rivaroxaban mylan co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events.  ------prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery.  treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults. -------adults prevention of stroke and systemic embolism in adult   patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - letrozolum - compresse rivestite con film - letrozolum 2.5 mg, lactosum monohydricum 61.5 mg, cellulosum microcristallinum, amylum pregelificatum, carboxymethylamylum natricum a corresp. natrium 0.14-0.21 mg, magnesii stearas, silica colloidalis anhydrica, Überzug: hypromellosum, talcum, macrogolum 8000, e 171, e 172 (flavum) pro compresso obducto. - cytostatikum - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - exemestanum - compresse rivestite con film - exemestanum 25 mg, mannitolum, hypromellosum, crospovidonum, polysorbatum 80, cellulosum microcristallinum, carboxymethylamylum natricum a, magnesii stearas, silica colloidalis anhydrica, Überzug: carmellosum natricum, maltodextrinum, glucosum monohydricum 0.441 mg, acidum stearicum, e 171, e 172 (flavum), pro compresso obducto corresp. natrium 0.15 - 0.25 mg. - 2nd e 3rd line terapia avanzata di mamma-ca nelle pazienti in postmenopausa - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - latanoprostum - collirio - latanoprostum 50 µg, natrii chloridum, natrii dihydrogenophosphas monohydricus et dinatrii phosphas corresp. phosphas 6.34 mg, aqua ad iniectabile, benzalkonii chloridum 0.2 mg, ad solutionem pro 1 ml. - il glaucoma - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - latanoprostum, timololum - collirio - latanoprostum 50 µg, timololum 5 mg ut timololi maleas, dinatrii phosphas et natrii dihydrogenophosphas monohydricus corresp. phosphas 6.33 mg, natrii chloridum, acidum hydrochloridum aut natrii hydroxidum ad ph, benzalkonii chloridum 0.2 mg, aqua ad iniectabile, ad solutionem pro 1 ml. - stretto, okuläre ipertensione - synthetika